Words of wisdom. Bladder cancers arise from distinct urothelial sub-populations by Bryan, Richard T & Ward, Douglas G
 
 
University of Birmingham
Words of wisdom. Bladder cancers arise from
distinct urothelial sub-populations
Bryan, Richard T; Ward, Douglas G
DOI:
10.1016/j.eururo.2014.11.058
License:
Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Bryan, RT & Ward, DG 2015, 'Words of wisdom. Bladder cancers arise from distinct urothelial sub-populations',
European urology, vol. 67, no. 3, pp. 590-1. https://doi.org/10.1016/j.eururo.2014.11.058
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
After an embargo period this document is subject to the conditions of a CC-BY-NC-ND license
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Bladder cancers arise from distinct urothelial sub-populations 
Jason Van Batavia, Tammer Yamany, Andrei Molotkov, Hanbin Dan, Mahesh Mansukhani, Ekaterina 
Batourina, Kerry Schneider, Daniel Oyon, Mark Dunlop, Xue-Ru Wu, Carlos Cordon-Cardo and Cathy 
Mendelsohn. 
Nature Cell Biology 2014; 16: 982–991. 
 
Expert’s Summary 1 
Using lineage-tracing techniques to indelibly label urothelial sub-populations in BBN carcinogenesis 2 
mouse models, the authors found that papillary-like and CIS-like lesions developed from different 3 
urothelial cell populations: non-invasive papillary lesions from intermediate cells of the urothelium 4 
and CIS lesions from keratin-5 expressing basal cells. These findings support a model in which the 5 
heterogeneity observed in bladder cancers is determined both by genetic changes and the cell 6 
lineage from which the tumour originates. These findings also provide a plausible explanation for 7 
clinical observations in humans regarding differences in natural history and prognosis of patients 8 
with different types of non-muscle-invasive lesion, and suggest that the difference in clinical 9 
outcomes may stem, at least in part, from a fundamental difference in the cell of origin. 10 
 11 
Experts’ Commentary 12 
"Bladder cancer or bladder cancers?" is a question that urological scientists have been asking for 13 
many years [1]: what are the molecular-genetic pathways that give rise to low-grade NMIBC, high-14 
grade NMIBC, CIS and MIBC? Some genetic abnormalities are common to all urothelial bladder 15 
cancer (UBC) subgroups such as TERT promoter mutations, and others are associated with LG-NMIBC 16 
(FGFR3 mutations) or HG-NMIBC/CIS/MIBC (TP53 mutations). Previous studies have suggested that 17 
invasive or aggressive UBCs can develop from basal cells [2;3], and that some UBCs exhibit protein 18 
and gene expression profiles indicative of an intermediate cell or luminal origin [4;5]. Van Batavia et 19 
al have now directly demonstrated that papillary and CIS/invasive lesions arise from distinct 20 
urothelial sub-populations, albeit in a model system which may not fully recapitulate tumourigenesis 21 
in the human bladder. It now seems increasingly likely that the context provided by the ‘cell of 22 
origin’ is key to both the oncogenic effects of the different genetic aberrations observed in LG-23 
NMIBC and HG-NMIBC/CIS/MIBC and to the very different behaviours of these two types of UBC.   24 
Many questions still remain. How do papillary tumours progress to MIBCs? Do papillary tumours 25 
always originate in the intermediate cell layer in humans?  Why do patients seemingly successfully 26 
treated for organ-confined disease relapse and succumb? Where do G3T1 tumours with mixed 27 
mutation profiles originate? It is these fundamental questions that approaches based upon baseline 28 
tumour characteristics, rather than outcomes, are yet to answer. The authors do not discuss 29 
important processes such as epithelial-mesenchymal transition or the development of cancer stem 30 
cells, but their elegant utilisation of morphologic approaches is refreshing in the era of next 31 
generation sequencing and has contributed significantly to our understanding of this challenging 32 
disease. 33 
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